John E.  Davis net worth and biography

John Davis Biography and Net Worth

VP of CryoLife
John Davis is Senior Vice President, Global Sales and Marketing. John has over 25 years of experience in sales and marketing leadership roles. Prior to joining CryoLife, John served as Executive Vice President Global Sales and Marketing at CorMatrix Cardiovascular. Prior to CorMatrix he served as Region Vice President in the Cardiac Rhythm Disease Management division at St. Jude Medical.

Among his significant previous positions, John spent 14 years at Medtronic. While at Medtronic, he served the Cardiac Rhythm Disease Management team, including six years as Vice President of the Southeast Region. John received several Medtronic awards including the President’s Club Award as Sales Representative and District Manager. He won the National Region of the Year while serving as Vice President. John received Medtronic’s Star of Excellence Award for his work in field force sizing and deployment. The Star of excellence is Medtronic's highest recognition for quality and innovation.

John received a bachelor’s degree from Western Carolina University.

What is John E. Davis' net worth?

The estimated net worth of John E. Davis is at least $0.00 as of March 5th, 2024. Mr. Davis owns 165,637 shares of CryoLife stock worth more than $0 as of April 26th. This net worth estimate does not reflect any other investments that Mr. Davis may own. Learn More about John E. Davis' net worth.

How do I contact John E. Davis?

The corporate mailing address for Mr. Davis and other CryoLife executives is 1655 Roberts Boulevard N.W, Kennesaw GA, 30144. CryoLife can also be reached via phone at (770) 419-3355 and via email at [email protected]. Learn More on John E. Davis' contact information.

Has John E. Davis been buying or selling shares of CryoLife?

John E. Davis has not been actively trading shares of CryoLife over the course of the past ninety days. Most recently, on Monday, November 29th, John E. Davis bought 600 shares of CryoLife stock. The stock was acquired at an average cost of $17.33 per share, with a total value of $10,398.00. Learn More on John E. Davis' trading history.

Who are CryoLife's active insiders?

CryoLife's insider roster includes John Davis (VP), Jean Holloway (SVP), Amy Horton (CAO), Dennis Maier (VP), Ronald McCall (Director), and Anthony Semedo (Director). Learn More on CryoLife's active insiders.

John E. Davis Insider Trading History at CryoLife

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/29/2021Buy600$17.33$10,398.00View SEC Filing Icon  
5/25/2021Sell12,739$29.66$377,838.7479,236View SEC Filing Icon  
9/16/2020Buy10,000$16.65$166,500.0070,451View SEC Filing Icon  
9/18/2018Sell3,333$33.86$112,855.3852,564View SEC Filing Icon  
7/26/2018Sell3,391$31.00$105,121.00View SEC Filing Icon  
7/6/2018Sell3,391$30.00$101,730.0052,746View SEC Filing Icon  
6/1/2018Sell4,373$28.00$122,444.00View SEC Filing Icon  
5/16/2018Sell4,373$27.00$118,071.0055,811View SEC Filing Icon  
4/17/2018Sell3,333$23.00$76,659.0054,771View SEC Filing Icon  
See Full Table

John E. Davis Buying and Selling Activity at CryoLife

This chart shows John E Davis's buying and selling at CryoLife by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CryoLife Company Overview

CryoLife logo
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $19.05
Low: $17.19
High: $21.72

2 Week Range

Now: N/A

Volume

7,792 shs

Average Volume

198,221 shs

Market Capitalization

$703.22 million

P/E Ratio

596.20

Dividend Yield

N/A

Beta

1.53